Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines
This study searched the literature using 4 key items and the Population, Intervention, Comparison, and Outcome: the efficacy and safety of poly-ADP ribose polymerase inhibitors in newly diagnosed advanced EOC; the efficacy and safety of intraperitoneal plus intravenous chemotherapy in optimally debulked advanced EOC; the efficacy and safety of secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer; and the efficacy and safety of the addition of bevacizumab to platinum-based chemotherapy in first platinum-sensitive recurrent EOC patients who received prior bevacizumab. The evidence for these recommendations, according to each key question, was evaluated using a systematic review and meta-analysis. The committee of ovarian cancer of the KSGO developed updated guidelines for treatments of EOC.PMID:38178704 | DOI:10.3802/jgo.2024.35.e43
Source: Journal of Gynecologic Oncology - Category: OBGYN Authors: Banghyun Lee Suk-Joon Chang Byung Su Kwon Joo-Hyuk Son Myong Cheol Lim Yun Hwan Kim Shin-Wha Lee Chel Hun Choi Kyung Jin Eoh Jung-Yun Lee Dong Hoon Suh Yong Beom Kim Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | OBGYN | Ovarian Cancer | Ovaries | Study